Elizabeth A Comen - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Elizabeth A Comen

Showing results (11-20 of 18) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 18 results.

Breast Cancer Research : BCR|December 12, 2018

CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE StudyJennifer D Brooks, Elizabeth A Comen, Anne S Reiner, et al.

Annals of Surgical Oncology|September 21, 2016

Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline UpdateAbram Recht, Elizabeth A Comen, Richard E Fine, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2017

Reply to L.B. Marks et alAbram Recht, Elizabeth A Comen, Richard E Fine, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2016

Practical Radiation Oncology|September 24, 2016

Clinical Breast Cancer|October 12, 2015

A Pilot Study of Dose-Dense Paclitaxel With Trastuzumab and Lapatinib for Node-negative HER2-Overexpressed Breast CancerNeil M Iyengar, Monica N Fornier, Steven M Sugarman, et al.

Nature|June 18, 2019

TOX is a critical regulator of tumour-specific T cell differentiationAndrew C Scott, Friederike Dündar, Paul Zumbo, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 28, 2016

A Pilot Study of Preoperative Single-Dose Ipilimumab and/or Cryoablation in Women with Early-Stage Breast Cancer with Comprehensive Immune ProfilingHeather L McArthur, Adi Diab, David B Page, et al.

Pageof 2

Search research articles

Showing results (11-20 of 18) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 18 results.

Breast Cancer Research : BCR|December 12, 2018

CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE StudyJennifer D Brooks, Elizabeth A Comen, Anne S Reiner, et al.

Annals of Surgical Oncology|September 21, 2016

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2017

Reply to L.B. Marks et alAbram Recht, Elizabeth A Comen, Richard E Fine, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2016

Practical Radiation Oncology|September 24, 2016

Clinical Breast Cancer|October 12, 2015

A Pilot Study of Dose-Dense Paclitaxel With Trastuzumab and Lapatinib for Node-negative HER2-Overexpressed Breast CancerNeil M Iyengar, Monica N Fornier, Steven M Sugarman, et al.

Nature|June 18, 2019

TOX is a critical regulator of tumour-specific T cell differentiationAndrew C Scott, Friederike Dündar, Paul Zumbo, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 28, 2016

A Pilot Study of Preoperative Single-Dose Ipilimumab and/or Cryoablation in Women with Early-Stage Breast Cancer with Comprehensive Immune ProfilingHeather L McArthur, Adi Diab, David B Page, et al.

Pageof 2